Skeletal effects, soy isoflavone, bone mineral density, BMD, bone markers, bone health, estrogen receptor, osteoclast, osteoblasts, postmenopausal women, bone turnover, genetic predisposition, hormonal status, osteoporosis.

https://doi.org/10.58396/bdhc020104

[1] Ho, S.C., Bacon, E., Harris, T., Looker, A., and Muggi, S. Hip rupture fees in Hong Kong and the United States, 1988–1989 Am J Public Fitness eighty-three: 694–697, 1993.

[2] Ross, P.D., Norimatsu, H., Davis, J.W., Yano, K., Wasnich, R.D., Fujiwara, S., Hosoda, Y., and Melton, J., III. assessment ofsmart rupture occurrence between native eastern, Japanese American, and American Caucasian societies, Am J Epidemiol 133: 801–809, 1991.

[3] Fujita, T., Yoshikawa, S., Ono, OK., Inoue, T., & Orimo, H. Usefulness of TC-80 (ipriflavone) tablets in osteoporosis: A multicenter, double-blind, fake tablet-regulated examination Igaku Noayumi 138: 113–141, 1986.

[4] Agnusdei, D., Camporeale, A., Zacchei, F., Gennari, C., Baroni, M.C., Costi, D., Biondi, M., Passeri, M., Ciacca, A., Sbrenna, C., Falsettini, E., and Ventura, A., outcomes of ipriflavone on cartilage bulk and cartilage upkeep in sufferers with settled postmenopausal osteoporosis. Curr Ther Res fifty-two: eighty-one–ninety-two, 1992.

[5] Markiewicz, L.; Garey, J.; Adlercreutz, H.; Gurpide, E. In vitro biochemical assays of nonsteroidal phytoestrogens J Steroid Biochem Mol Biol 45: 399–405, 1993.

[6] Tune, T.T., Hendrich, S., and Murphy, P.A. Estrogenic motion of glycitein, a soy isoflavone J Agric Meals Chem 47: 1607–1610, 1999.

[7] Breslau, N. A., Brinkley, L., Hill, OK. D., and Pak, C. Y. C., dating betwixt animal protein-wealthy diet and type of rock establishment and calcium absorption J Clin Endocrinol Metabol 66: a hundred and 40–146, 1988.

[8] eight. Anderson, J. J. B., and Alekel, D. L. Skeletal property of phytoestrogens in humans: cartilage now, not organic bulk, and cartilage indicators Phytoestrogens and Health, Eds. Gilani, G.S., and Anderson, J.J.B., American Oil Chemists' Society Press, Champaign, IL, 2002, pp. 341–353.

[9] nine. Anthony, M.S., Anderson, J.J.B., and Alekel, D.L., Affiliation between soy and/or isoflavones and cartilage: proof from epidemiological studies. Phytoestrogens and fitness, Eds., Gilani, G.S., and Anderson, J.J.B., American Oil Chemists' SocietyPress, Champaign, IL, 2002, pp. 331–340.

[10] Anderson, J.J.B., and Garner, S.C., Phytoestrogens and Bone Balliere's Clin Endocrinol Metab 12:1–15, 1998. Balliere's Clin Endocrinol Metab 12: 1–15, 1998.

[11] Messina, M., Gugger, E. T., and Alekel, D. L. Soy protein, soybean isoflavones, and cartilage health: an evaluation of animal and human files Soy protein, soybean isoflavones, and cartilage power: an evaluation of the animal and human file within the guide of Nutraceuticals and purposeful ingredients, R.E.C. Wildman (Ed.), CRC Press, Boca Raton, FL, 2001, pp. 77–98,

[12] Arjmandi, B.H. The role of phytoestrogens in the stop and state of affairs of osteoporosis in ovarian start manipulation technique imperfection J Am Coll Nutr. 20 (Suppl. 5): 398S–402S, 417S–420S, 2001.

[13] Scheiber, M.D.; Rebar, R.W. Isoflavones and postmenopausal cartilage well-being: a possible alternative to estrogen treatment? Menopause 6: 233–241, 1999.

[14] Doren, M., and Samsioe, G. Prevention of postmenopausal osteoporosis accompanying estrogen substitute remedies and joined compounds: renewing dispassionate issues due to the fact 1995. Hum Reprod Update 6: 419–426, 2000.

[15] Setchell, OK.D., and Cassidy, A. dietary isoflavones: organic assets and pertinence to human well-being J Nutr 129: 758S–767S, 1999.

[16] Kurzer M.S., Xu X., Nutritional phytoestrogens. Annu Rev Nutr 17: 353–381, 1997.

[17] Liberman, S. Are the dissimilarities betwixt estradiol and introduced estrogens always happening or artificial, truly bearing on syntax? J Clin Endocrinol Metab 81: 850, 1996.

[18] Setchell, ok. D.R. Non-steroidal estrogen of abstinence from food inception: workable responsibility in well-being and agony, absorption, and corporal property Proc Nutr Soc NZ 20: 1–21, 1995.

[19] Vidal, O., Kindblom, L. G., and Ohlsson, C. Expression and localization of estrogen receptor- in rodent and human cartilages J Bone Mineral Res 14: 923–929, 1999.

[20] Shutt, D. A.; Cox, R. I. Steroid and phytoestrogen binding to chief uterine receptors is artificial. Steroid and phytoestrogen binding in a mass of water debris in air uterine receptors is artificial. Endo Chronicle fifty-two: 299–310, 1972

[21] Kuiper, G.G., Lemmen, J.G., Carlsson, B., Corton, J.C., Secure, S.H., Camper der Saag, P.T., Camper der Burg, B., and Gustafsson, J.A., the interaction of estrogenic chemical compounds and phytoestrogens accompanying estrogen receptors Endocrinology 139: 4252–4263, 1998.

[22] Melton, L.J., III; Chrischilles, E.A.; Cooper, C.; Lane, A.W.; Riggs, B.L. attitude: how many wives do you have with osteoporosis? J Bone Miner Res 7: 1005–1010, 1992.

[23] Cummings, S. R.; Melton, L. J., III. Osteoporosis I: Epidemiology and Results of Osteoporotic Fractures Lancet 359: 1761–1767, 2002.

[24] De Laet, C.E., Camper Hout, B.A., Burger, H., Hofman, A., and Pols, H.A. Bone mass and hazard of modern-day rupture in human beings interested in something: a pass-localized look at Br Med J 315: 221–225, 1997.

[25] Tucci, J.R., Osteoporosis Renovation Med fitness R I 81: 169–seventy-three, 1998.

[26] Melton, L. J., III; Therneau, T. M.; Larson, D. R., Long-time period flows in elegant ruin predominance: the influence of contemporary rupture occurrence and endurance. Osteoporos Int. 8: 68–74, 1998.

[27] Rogmark, C., Sernbo, I., Johnell, O., and Nilsson, J.-., the incidence of recent fractures Malmö, Sweden, 1992–1995. Acta Orthopaed Scand 70: 19–22, 1999.

[28] Cooper, C., Campion, G., and Melton, L. J. III. Hip fractures in the elderly: a standard prediction. Osteoporos Int 2: 285–289, 1992.

[29] Genant, H.ok., Cooper, C., bad, G., Reid, I., Ehrlich, G., Kanis, J., Nordin, B.E.C., Barrett-Connor, E., Black, D., Bonjour, J.-P., Dawson-Hughes, B., Delmas, P.D., Dequeker, J., Ragi Eis, S., Gennari, C., Johnell, O., Johnston, C.C., Jr., Lau, E.M.C., Liberman, Lindsay, R., Martin, T.J., Masri, Mautalen, C.A., Meunier, P.J., Miller, P.D., Mithal, Morii, H., Papapoulos, S., Woolf, A., Yu, W., Khaltaev, N., Khaltaev, Khaltaev, for Osteoporosis. Osteoporos Int 10: 259–264, 1999.

[30] Melton, L.J., III; Riggs, B.L. Epidemiology of person-related fractures Osteoporotic Syndrome, Ed. Avioli, A.V., New York, Grune and Stratton, 1983, pp. 45–72.

[31] Melton, L.J., III. Who has osteoporosis? The conflict between dispassionate and community fitness outlooks J Bone Miner Res 15: 2309–2314, 2000.

[32] Kanis, J.A., Melton, L.J., III, Christiansen, C., Johnston, C.C., and Khaltaev, N.: Prognosis of osteoporosis. J Bone Miner Res 9: 1137–1141, 1994.

[33] Melton, L.J., III., On what number of other halves do you have osteoporosis? J Bone Miner Res., 10: a hundred seventy-five–177, 1995.

[34] Cummings, S.R., Nevitt, M.C., Browner, W.S., Stone, OK., Fox, OK.M., Ensrud, OK.E., Cauley, J., Black, D., and Vogt, T.M., chance determinants for stylish fractures in Caucasian moms. examine the osteoporotic rupture studies organization. N Engl J Med 332: 767–773, 1995.

[35] Anderson, J. J. B. Pollitzer, and W. S. Ethnic and ancestral distinctnesses: resistance to osteoporotic fractures Advances in dietary studies, Vol. 9, Ed. Harold H. Draper Plenum Press, The Big Apple, 1994, lad. 8.

[36] Looker, A.C., Orwoll, E.S., Johnston, C.C., Jr., Lindsay, R.L., Wahner, H.W., Dunn, W.L., Calvo, M.S., Harris, T.B., and Heyse, S.P., the incidence of reduced femoral cartilage mass in earlier American folks from NHANES III. J Bone Miner Res 12: 1761–1768, 1997.

[37] Silverman, S.L., and Madison, R.E., decreased incidence of present-day fractures in Hispanics, Asians, and Blacks: California Clinic Discharge Dossier Am J Public Health 78: 1482–1483, 1988.

[38] Tsai, okay.S. Osteoporotic wreck price, cartilage no longer having natural bulk, and cartilage absorption in Taiwan J Formos Med Assoc. ninety-six: 802–805, 1997.

[39] Xu, L., Lu, A., Zhao, X., Chen, X., and Cummings, S. R. Very reduced prices of new smash have taken place in Beijing, according to humans as political entities in the Republic of China and the Beijing Osteoporosis Task. Am J Epidemiol one hundred forty-four: 901–907, 1996.

[40] Chin, OK., Evans, M.C., Cornish, J., Cundy, T., and Reid, I.R., differences in chic stem and femoral narrow connector distance in premenopausal wives of Polynesian, Asian, and European origin. Osteoporos Int 7: 344–347, 1997.

[41] Alekel, D. L., Mortillaro, E., Hussain, E. A., West, B., Ahmed, N., Peterson, C. T., Werner, R. Ok., Arjmandi, B. H., and Kukreja, S. C. way of life and natural subscribers to close to leg part cartilage now not natural bulk and elegant stem time in apparent racial groups of premenopausal moms. Osteoporos Int 9: 327–338, 1999.

[42] Parker, M., Anand, J. okay., Myles, J. W., and Lodwick, R. Proximal femoral fractures: predominance of detached ethnic agencies Eur J Epidemiol 8: 730–732, 1992.

[43] Ho, S. C., Wong, E., Chan, S. G., Lau, J., Chan, C., and Leung, P. C. The purpose of height cartilage bulk in Chinese other halves has been antique 21–40 age. III. bodily activity and cartilage now have organic bulk. J Bone Miner Res 12: 1262–1271, 1997.

[44] Lau, E. M. C., Suriwongpaisal, P., Lee, J. K., Das De, S., Festin, M. R., noticed, S. M., Khir, A., Torralba, T., Sham, A., and Sambrook, P. Risk determinants for elegant spoilage in Asian people of community: The Asian Osteoporosis Study J Bone Miner Res 16: 572–580, 2001.

[45] Davis, J.W., Novotny, R., Wasnich, R.D., and Ross, P.D. Ethnic, anthropometric, and conduct determinants of manual territorial differences in top cartilage bulk Calcif Tissue Int sixty-five: 100–a hundred and 5, 1999.

[46] Prentice, A.; Parsons, T.J.; Cole, T.J. The unfussy use of cartilage no longer organic bulk in absorptiometry concedes the opportunity to bring about period-accompanying artifacts within the labeling of cartilage no longer organic cause. Am J Clin Nutr 60: 837–842, 1994.

[47] Ross, P.D., He, Y.-F., Yates, A.J., Coupland, C., Ravn, P., McClung, M., Thompson, D., and Wasnich, R.D. The frame amount offers cause for most of the distinctnesses in cartilage mass between Asian and Caucasian ladies. Calcif Tissue Int 59: 339–343, 1996.

[48] Cummings, S.R., Cauley, J.A., Palermo, L., Ross, P.D., Wasnich, R.D., Black, D., and Faulkner, K.G. Racial distinctnesses in fashionable pivot lengths concede the opportunity to exhibit ethnic distinctnesses in stylish ruin fees. Osteoporosis Int 4: 226–229, 1994.

[49] Nakamura, T., Turner, C.H., Yoshikawa, T., Slemenda, C.W., Peacock, M., Burr, D.B., Mizuno, Y., Orimo, H., Ouchi, Y., and Johnston, C.C., Jr. Do alternatives in current mathematics analyze the dissimilarities in modern damage hazards between Japanese and White Americans? J Bone Miner Res 9: 1071–1076, 1994.

[50] Alekel, D. L., Peterson, C. T., Werner, R. OK., Mortillaro, E., Ahmed, N., and Kukreja, S. C. Body length, ethnic background,conduct, and organic subscribers to local and volumetric lumbar backbone cartilage now not natural bulk in Indian/Pakistani and American Caucasian premenopausal other halves J Clin Densitometry 5: a hundred seventy-5–186, 2002.

[51] Alekel, D.L., St. Germain, A., Peterson, C.T., Hanson, OK.B., Stewart, J.W., and Toda, T. Isoflavone-wealthy soy protein disengagement attenuates cartilage misfortune in the lumbar backbone of perimenopausal ladies. Am J Clin Nutr seventy-two: 844–852, 2000.

[52] Potter, S.M., Baum, J.A., Teng, H., Stillman, R.J., Shay, N.F., and Erdman, J.W., Jr., consequences of soy protein and isoflavones on ancestry lipids and cartilage bulk in postmenopausal girls Am J Clin Nutr 68: 1375S–1379S, 1998.

[53] Chen, Z., Zheng, W., Custer, L.J., Dai, Q., Shu, X.-O., Jin, F., and Franke, A.A., nutritional use of soy snacks and charm equivalence accompanying the defecation rate of isoflavonoids in adventure excretion samples with Chinese-language daughters in Shanghai. Nutr Most Cancers 33: 82–87, 1999.

[54] Kimira, M., Arai, Y., Shimoi, K., and Watanabe, S., eastern consumption of flavonoids and isoflavonoids from delicacies J Epidemiol 8: 168–175, 1998.

[55] Maskarinec, G., Singh, S., Meng, L., and Franke, A. A., dietary soy consumption and urinary isoflavone expulsion between daughters in a multiethnic human being most cancers Epidemiol Biomark Prev 7: 613–619, 1998. 

[56] Ross, P.D., Fujiwara, S., Huang, C., Davis, J.W., Epstein, R.S., Wasnich, R.D., Kodama, okay., and Melton, J., III. Vertebral rupture predominance in moms in Hiroshima outstanding to Caucasians or Japanese daughters inside the U.S. Int J Epidemiol 24: 1171–1177, 1995.

[57] Tsai, okay., Twu, S., Chieng, P., Yang, R., and Lee, T., the incidence of vertebral fractures in Chinese people in Taiwanese towns. Calcif Tissue Int 59: 249–253, 1996.

[58] Tsai, okay., Huang, K., Chieng, P., and Su, C. Bone is not the natural bulk of ordinary Chinese daughters in Taiwan. Calcif Tissue Int 48: 161–166, 1991.

[59] family members, K., Lee, E., Kushida, ok., Sartoris, D.J., Ohmura, A., Clopton, P.L., Inque, T. Bone bulk and cloth arrangement at the Pacific Rim: a corresponding middle from points Japan-Born and U.S.-innate Japanese American other halves J Bone Mineral Res 8: 861–869, 1993.

[60] Davis, J.W., Ross, P.D., Nevitt, M.C., and Wasnich, R.D., occurrence of falls among Japanese human beings inquisitive about something in Hawaii J Clin Epidemiol 50: 589–594, 1997.

[61] Somekawa, Y., Chiguchi, M., Ishibashi, T., and Aso, T. Soy intake had references to menopausal manifestations, antitoxin lipids, and cartilage, not natural bulk, in postmenopausal Japanese mothers. Obstet Gynecol Ninety-Seven: 109–a hundred and fifteen, 2001.

[62] Tsuchida is okay; Mizushima is okay; Toba is okay; and Soda is okay. nutritional soybean intake and cartilage, not organic mass, among 995 middle-vintage daughters in Yokohama. J Epidemiol 9: 14–19, 1999.

[63] Greendale, G.A., FitzGerald, G., Huang, M.-H., Sternfeld, B., Gold, E., Seeman, T., Sherman, S., and Sowers, M.F. Nutritional soy isoflavones and cartilage now not organic mass: effects from a study of women energy throughout the United States with its very own government Am J Epidemiol, 155: 746–754, 2002.

[64] Kardinaal, A.F.M., Morton, M.S., Bruggemann-Rotgans, I.E.M., camper Beresteijn, E.C.H. Phytoestrogen expulsion and rate of cartilage deficit in postmenopausal daughters Eur J Clin Nutr 52: 850–855, 1998. 

[65] Thompson, L. U., Robb, P., Serrano, M., and Cheung, F. Mammalian lignans result from differing meals. Nutr Cancer 16: 43–52, 1991. 

[66] Zhang, X., Shu, X.-O., Li, H., Yang, G., Li, Q., Gao, Y.-T., Zheng, W. Prospective follower study of soy bread devouring and risk of cartilage rupture between postmenopausal daughters Arch Intern Med 165: 1890–1895, 2005. 

[67] B. L., Khosla, S., and Melton, L. J., III. A complete model for involutional osteoporosis: estrogen imperfection causes type I and type II osteoporosis in postmenopausal mothers and causes cartilage misfortune in developing guys. J Bone Miner Res 13: 763–773, 1998. 

[68] Komulainen, M., Kroger, H., Tuppurainen, M.T., Heikkinen, A.M., Alhava, E., Honkanen, R., Jurvelin, J., Saarikoski, S. Prevention of femoral and lumbar cartilage misfortune accompanying birth control method substitute medicine and source of nourishment D3 in early postmenopausal wives: A community-located 5-period randomized trial 1999, J Clin Endocrinol Metab 84: 546-552. 

[69] Cauley, J.A., Seeley, D.G., Ensrud, K., Ettinger, B., Black, D., and Cummings, S.R. Estrogen substitute medicine and fractures in earlier mothers Study of the osteoporotic break research group 1995, Ann Intern Med 122: 9-16. 

[70] Manolagas, S. C., and Jilka, R. L. Mechanisms of affliction: cartilage essence, cytokines, and cartilage renovation: Emerging visions into the pathophysiology of osteoporosis 1995, N Engl J Med 332:305-311. 

[71] Scharbo-DeHaan, M. Hormone substitute analysis Nurs: Pract. 21 (12 Pt. 2): 1–13, 1996. 

[72] Beresford S.A.A., Weiss N.S., McKnight B. Risk of endometrial malignancy having to do with the use of estrogen-linked accompanying recurrent progestagen medicine in postmenopausal girls. Lancet 349: 458–461, 1997. 

[73] Writing Group for Women's Health Initiative Investigators Risks and benefits of estrogen and progestin in healthy postmenopausal girls JAMA 288: 321-333, 2002. 

[74] McNagny, S.E., Prescription of birth control methods as substitute cures for menopausal syndromes. Ann Intern Med 131: 605–616, 1999. 

[75] Eastell, R. Postmenopausal osteoporosis situation, N Engl J Med 338: 736-746, 1998. 

[76] Kessel, B. Alternatives to estrogen in menopausal wives Proc Soc Exp Biol Med 217(1): 38–44, 1998. 

[77] Groeneveld, F.P., Bareman, F.P., Barentsen, R., Dokter, H.J., Drogendijk, A.C., Hoes, A.W. The duration of hormonal substitute analysis is usually practiced as an effect study. Maturitas 29: 125–131, 1998. 

[78] Schneider D.L., Barrett-Connor E.L., and Morton D.J., Timing of postmenopausal estrogen for optimum cartilage, not organic mass. Rancho Bernardo Study, JAMA 277: 543-547, 1997. 

[79] U.S. Preventive Services Task Force Postmenopausal birth control methods substitute a cure for the basic stop of incessant environments: Recommendations and action. Ann Intern Med 137: 834–839, 2002.

[80] Fleisch, H. Bisphosphonates in osteoporosis: an initiation Osteoporosis Int. 3: S3–S5, 1993. 

[81] Watts, N.B. Treatment of osteoporosis accompanying bisphosphonates Rheum Dis Clin N Am 27: 197–214, 2001. 

[82] Adachi, J.D., Bensen, W.G., Brown, J., Hanley, D., Hodsman, A., Josse, R., Kendler, D.L., Lentle, B., Olszynski, W., St. Marie, L.-G., Tenenhouse, A., & Chines, A.A. Interdenominational analysis for fear of corticosteroid-inferred osteoporosis. N Engl J Med 337: 382–387, 1997. 

[83] Liberman, U.A., Weiss, S.R., Broll, J., Minne, H.W., Quan, H., Bell, N.H., Rodriguez-Portales, J., Downs, R.W., Jr., Dequeker, J., Favus, M. Effect of spoken alendronate on cartilage, not organic bulk, and the occurrence of fractures in postmenopausal osteoporosis Alendronate Phase III Osteoporosis Treatment Study Group N Engl J Med 333(22): 1437–1443, 1995. 

[84] Karpf, D.B.; Shapiro, D.R.; Seeman, E.; Ensrud, K.E.; Johnston, C.C.; Adami, S.; Harris, S.T.; Santora, A.C.; Hirsch, L.J.; Oppenheimer, L.; Thompson, D. Prevention of nonvertebral fractures by alendronate: a meta-study JAMA 277(14): 1159–1164, 1997. 

[85] Overgaard, K., Hansen, M. A., Jensen, S. B., and Christiansen, C. Effect of following a timed nasal presidency of calcitonin on cartilage bulk and rupture rates in settled osteoporosis: A prescription-answer study. Br Med J 305: 556–561, 1992. 

[86] Thamsborg G.: Effect of a nasal combination of red and yellow calcitonin on calcium and cartilage absorption. Dan Med Bull 46: 118–126, 1999. 

[87] Silverman, S.L.: Calcitonin. Rheum Dis Clin N Am 27: 187–196, 2001. 

[88] Ilich, J.Z.; Kerstetter, J.E. Nutrition in cartilage energy is called A lie further calcium. J Am Coll Nutr 19: 715-737, 2000. 

[89] North American Menopause Society. The act of calcium in fairy- and postmenopausal girls: the unity belief of the North American Menopause Society Menopause 8: 84–95, 2001. 

[90] Morgan, S.L., Calcium, and Source of Nutrition D Levels in Osteoporosis. Rheum Dis Clin N Am 27: 101–130, 2001. 

[91] Food and Nutrition Board, Institute of Medicine Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride Washington, D.C.: National Academy Press, 1997. 

[92] Heaney, R.P. Calcium, creamery devices, and osteoporosis J Am Coll Nutr 19: 83S–99S, 2000. 

[93] Nieves, J.W., Komar, L., Cosman, F., Lindsay, R. Calcium potentiates the effect of estrogen and calcitonin on cartilage bulk: review and reasoning Am J Clin Nutr 67: 18–24, 1998. 

[94] Lips, P., Duong, T., Oleksik, A., Black, D., Cummings, S., Cox, D., Nickelsen, T. A all-encompassing study of source of nourishment D rank and parathyroid function in postmenopausal mothers accompanying osteoporosis: a standard dossier from the diversified consequences of raloxifene judgment in a dispassionate trial J Clin Endocrinol Metab 86: 1212–1221, 2001. 

[95] Kantorovich, V., Gacad, M.A., Seeger, L.L., and Adams, J.S. Bone, not organic bulk, increases accompanying source of nourishment D satiation in inmates with accompanying source of nourishment D lack and basic hyperparathyroidism. J Clin Endocrinol Metab 85: 3541–3543, 2000. 

[96] Adams, J.S., Kantorovich, V., Wu, C., Javanbakht, M., and Hollis, B.W. Resolution of the source of nourishment D lack in osteopenic victims results in fast improvement of cartilage, not organic mass. J Clin Endocrinol Metab 84: 2729–2730, 1999. 

[97] Bryant, H. U.; Dere, W. H. Selective estrogen receptor modulators: an alternative to birth control methods and a substitute cure Proc Soc Exp Biol Med 217(1): 45–52, 1998. 

[98] Havsteen B. Flavonoids, a class of normal compounds accompanying extreme pharmacological effectiveness Biochem Pharmacol 32: 1141–1148, 1983. 

[99] Agnusdei, D., Zacchei, F., Bigazzi, S., Cepollaro, C., Nardi, P., Montagnani, M., Gennari, C. Metabolic and dispassionate effects of ipriflavone in postmenopausal osteoporosis Drugs Exp Clin Res 15: 97–104, 1989. 

[100]Yamazaki I, Shino A, Shimizu Y., Tsukuda R., Shirakawa Y., and Kinoshita M. Effect of ipriflavone on glucocorticoid-inferred osteoporosis in rats Life Sci. 38: 951–958, 1986. 

[101]Yamazaki, I., Shino, A., and Tsukuda, R. Effect of ipriflavone on ovariectomy-induced osteoporosis in rats J Bone Min Metab 3: 205-210, 1986. 

[102]Dei D., Gennari C., and Bufalino L. Prevention of early postmenopausal bone loss using low doses of conjugated estrogens and the non-hormonal, bone-active drug ipriflavone Osteoporos Int 5(6): 462-466, 1995. 

[103]Alexandersen, P., Toussaint, A., Christiansen, C., Devogelaer, J.-P., Roux, C., Fechtenbaum, J., Gennari, C., and Reginster, J.Y., for the Ipriflavone Multicenter European Fracture Study: Ipriflavone in the Treatment of Postmenopausal Osteoporosis. JAMA 285: 1482–1488, 2001.

[104]Wright, C.D.P., Garrahan, N.J., Stanton, M., Gazet, J.-C., Mansell, R.E., and Compston, J.E. Effect of long-term tamoxifen therapy on cancellous bone remodeling and structure in women with breast cancer J Bone Miner Res 9: 153–159, 1994. 

[105]Love, R.R., Mazess, R.B., Barden, H.S., Epstein, S., Newcomb, P.A., Jordan, V.C., Carbone, P.P., and De Mets, D.L. Effects oftamoxifen on bone mineral density in postmenopausal women with breast cancer N Engl J Med 326: 852–856, 1992. 

[106]Fornander, T., Rutquist, L.E., Cedermark, B., Glas, U., Mattsson, A., Silfversward, C., Skoog, L., Somell, A., Theve, T., Wilking, N., Askergren, J., Hjalmar, M.-L. Adjuvant tamoxifen for early breast cancer: occurrence of new primary cancers Lancet 1: 117–120, 1989. 

[107]Delmas, P.D., Bjarnason, N.H., Mitlak, B.H., Ravoux, A.-C., Shah, A.S., Huster, W.J., Draper, M., Christiansen, C. Effects of raloxifene on bone mineral density, serum cholesterol concentration, and uterine endometrium in postmenopausal women N Engl J Med 337: 1641–1647, 1997. 

[108]Heaney, R. P.; Draper, M. W. Raloxifene and estrogen: comparative bone remodeling kinetics J Clin Endocrinol Metab 82: 3425–3429, 1997. 

[109]Walsh, B.W., Kuller, L.H., Wild, R.A., Paul, S., Farmer, M., Lawrence, J.B., Shah, A.S., and Anderson, P.W. Effects of raloxifene on serum lipid and coagulation factor levels in healthy postmenopausal women JAMA 279(18): 1445–1451, 1998. 

[110]Gordon, S., Walsh, B.W., Ciaccia, A.V., Siddhanti, S., Rosen, A.S., Plouffe, L. Transition from estrogen-progestin to raloxifene in postmenopausal women: Effect on vasomotor symptoms Obstet Gynecol 103: 267–273, 2004. 

[111]St. Germain, A., Peterson, C.T., Robinson, J., and Alekel, D.L. Isoflavone-rich or isoflavone-poor soy protein did not reduce menopausal symptoms during the 24 weeks of treatment. Menopause, 8(1): 17–26, 2001 

[112]Arjmandi, B.H., Alekel, L., Hollis, B.W., Amin, D., Stacewicz-Sapuntzakis, M., Guo, P., and Kukreja, S.C. Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J Nutr 126: 161–167, 1996. 

[113]Arjmandi, B.H., Salih, M.A., Herbert, D.C., Sims, S.H., Kalu, D.N. Evidence of estrogen receptor-linked calcium transport in the intestine Bone Miner 21: 63–74; 1993. 

[114]Spence, L.A., Lipscomb, E.R., Cadogan, J., Martin, B., Wastney, M.E., Peacock, M., and Weaver, C.M. Effect of soy isoflavones on calcium metabolism in postmenopausal women: A randomized crossover study Am J Clin Nutr 81: 916–922, 2005. 

[115]Pennington, J.A.T. Bowes, and the Church's Food Values of Portions Commonly Used, 17th ed. Harper and Row (1998) 

[116]Anderson, J.J.B., Thomsen, K., and Christiansen, C. High-protein meals, insular hormones, and urinary calcium excretion in human subjects In Proceedings of the International Symposium on Osteoporosis, Eds., C. Christiansen, J.S. Johansen, and B.J. Riis, N? haven A/S, Viborg, Denmark, 1987, 

[117]Pie, J.-E.; Paik, H.Y. The effect of meat protein and soy protein on calcium metabolism in young adult Korean women Korean J Nutr 19: 32-40, 1986, 

[118]Sebastian, A. Low versus high meat diets: effects on calcium metabolism J Nutr 133: 3237-3238, 2003. 

[119]Watkins, T.R., Pandya, K., and Mickelsen, O. Urinary acid and calcium excretion: effect of soy versus meat in human diets In Nutritional Bioavailability of Calcium, Ed. Kies, C. American Chemical Society, Washington, D.C., 1985

[120]Roughead, Z.ok., Hunt, J.R., Johnson, L.ok., Badger, T.M., and Lykken, G.I., managed substitution of soy protein for meat protein: outcomes on calcium retention, bone, and cardiovascular fitness indices in postmenopausal ladies. J Clin Endocrinol Metab 90: 181–189, 2005.

[121]Kerstetter, J.E., O'Brien, K., and Insogna, OK., nutritional protein and intestinal calcium absorption, Am J Clin Nutr 73: 990–992, 2001.

[122]Pun, okay.ok., Chan, L.W.L., Chung, V., and Wong, F.H.W. Calcium and different nutritional components in Hong Kong Chinese regarding age and osteoporosis J Appl Nutr forty-three: 12–17, 1990.

[123]Kung, A.W.C., Luk, OK. D.k., Chu, L.W., and Chiu, P.okay.Y. Age-related osteoporosis in Chinese: an evaluation of the reaction of intestinal calcium absorption and calcitropic hormones to nutritional calcium deprivation Am J Clin Nutr 68: 1291–1297, 1998.

[124]Heaney, R.P., Recker, R.R., and Stegman, M.R., may also be A.J. Calcium absorption in ladies: relationships to calcium consumption, estrogen reputation, and age. J Bone Miner Res: 469–475, 1989.

[125]Weaver, C.M. Calcium necessities: the need to apprehend racial variations Editorial. Am J Clin Nutr 68: 1153–1154, 1998.

[126]Lau, E.M.C., Osteoporosis in Asians: The Function of Calcium and Different Nutrients Mod Med 7: 45–50, 1994.

[127]Kreijkamp-Kaspers, S., Kok, L., Grobbee, D.E., de Haan, E.H.F., Aleman, A., Lampe, J.W., and van der Schouten, Y.T., the effect of soy protein containing isoflavones on cognitive characteristics, bone mineral density, and plasma lipids in postmenopausal women JAMA 292: 65–74, 2004.

[128]Gallagher, J.C., Satpathy, R., Rafferty, K., and Haynatzka, V. The effect of soy protein isolate on bone metabolism Menopause11: 290–298, 2004

[129]Dallas, F.S., Rice, G.E., Wahlqvist, M.L., Grehan, M., Murkies, A.L., Medley, G., Ayton, R., and Strauss, B.J.G. Effects of dietary phytoestrogens in postmenopausal women Climacteric 1: 124–129, 1998.

[130]Lydeking-Olsen, E.; Beck-Jensen, J.-E.; Setchell, okay. D.R., Holm-Jensen, T. Soy milk or progesterone for preventing bone loss: a 2 year randomized, placebo-managed trial. Eur J Nutr forty-three: 246–257, 2004

[131]Ho, S.C., Chan, S.G., Yi, Q., Wong, E., Leung, %. Soy consumption and the protection of peak bone mass in Hong Kong Chinese girls. J Bone Miner Res 16: 1363–1369, 2001.

[132]Hsu, C.-S., Shen, W.W., Hsueh, Y.-M., and Yeh, S.-L. Soy isoflavone supplementation in postmenopausal ladies: consequences on plasma lipids, antioxidant enzyme sports, and bone density. J Reprod Med 46: 221–226, 2001.

[133]Chen, Y.-M., Ho, S.C., Lam, S.S.H., Ho, S.S.S., and Woo, J.L.F. Soy isoflavones have a good impact on bone loss in Chineselanguage postmenopausal women with decreased bone mass: A double-blind, randomized, controlled trial. J Clin Endocrinol Metab 88: 4740–4747, 2003.

[134]Harkness, L.S., Fiedler, K., Sehgal, A.R., Oravec, D., and Lerner, E. decreased bone resorption with soy isoflavone supplementation in postmenopausal ladies. J Women's Health 13: a thousand–1007, 2004.

[135]Pines, A., Katchman, H., Villa, Y., Mijatovic, V., Dotan, I., Levo, Y., Ayalon, D. The impact of diverse hormonal arrangements and calcium supplementation on bone mass in early menopause. Is there a predictive value for the preliminary bone density and body weight? J Intern Med 246: 357–61, 1999

[136]Heaney, R.P., The Bone-Remodeling Brief: Implications for the Translation of Clinical Research on Bone Mass Change J Bone Miner Res 9: 1515–1523, 1994.

[137]Souberbielle, J.C., Cormier, C., and Kindermans, C. Bone markers in medical practice Curr Opin Rheu Metal 11: 312–319, 1999.

[138]Ross, P.D., Predicting bone loss and fracture hazards with biochemical markers: an overview J Clin Density Geometry 2: 285–294, 1999.

[139]Garnero P., Markers of bone turnover for the prediction of fracture risk. Osteoporos Int 11 (Suppl 6): S55–65, 2000.

[140]Delmas, P.D., Eastell, R., Garnero, P., Seibel, M.J., and Stepan, J., Committee of Clinical Advisors of the Global Osteoporosis Basis the use of biochemical markers of bone turnover in osteoporosis. Osteoporosis Int. 11 (Suppl. 6): S2–17, 2000.